| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 03/06/2003 | US20030045709 Crystalline forms of carbapenem intermediates |
| 03/06/2003 | US20030045531 Antileukemia and antitumor agents |
| 03/05/2003 | EP0992491B1 Processes for producing azetidine-2-carboxylic acid and intermediates thereof |
| 03/04/2003 | US6528503 Anticoagulants |
| 03/04/2003 | CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 02/27/2003 | WO2003016543A2 Enzymatic resolution of t-butyl taxane derivatives |
| 02/25/2003 | US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 02/25/2003 | US6525052 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/20/2003 | WO2003014081A1 Process for producing optically active azetidine-2-carboxylic acid |
| 02/20/2003 | WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | US20030036650 For use in producing amino acid derivative antibiotics |
| 02/20/2003 | CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/19/2003 | EP0690867B1 Taxanes having furyl or thienyl substituted side-chain |
| 02/19/2003 | CN1398255A New couling process |
| 02/18/2003 | US6521660 3′-alkyl substituted taxanes and pharmaceutical compositions containing them |
| 02/18/2003 | US6521619 Bind to the interaction-domain of integrin lfa-1 interrupting enothelial cell-leukocyte adhesion |
| 02/18/2003 | US6521612 Antibiotic compounds |
| 02/18/2003 | US6521432 Methods for enhancing the rate of modification of metastable bonds |
| 02/13/2003 | US20030028976 For oxidation dyeing of hair |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | CN1101397C Preparation of beta-methyl carbepenem intermediate |
| 02/11/2003 | US6518434 Coupling process |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/06/2003 | US20030027812 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 02/06/2003 | US20030027797 For therapy of metabolic disorders related to insulin resistance or hyperglycemia |
| 02/06/2003 | US20030026521 Optical interleaver |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/04/2003 | US6515179 Process for the removal of nitrobenzenesulfonyl |
| 02/04/2003 | US6515011 Anticoagulants |
| 02/04/2003 | US6514961 Such as anxiety and all forms of epilepsy, particularly in humans |
| 01/30/2003 | WO2003007939A1 Azetidine derivatives and their use as ccr3 receptor antagonists |
| 01/30/2003 | US20030022891 Melanin-concentrating hormone (MCH); treating metabolic and eating disorders, such as hyperphagia, and diabetes; urea, thiourea and cyano-guanidine compounds of given formula |
| 01/29/2003 | EP1278728A1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 01/29/2003 | EP0910573B1 New amino acid derivatives and their use as thrombin inhibitors |
| 01/29/2003 | CN1393442A Process for synthesizing L-N-protective group-azacyclobutane-2-carboxylic acid |
| 01/22/2003 | CN1392137A New cyclic alpha-amino-gamma hydroxy amide compound, its preparing method and medicinal composition containing said compound |
| 01/22/2003 | CN1099425C 新的肽衍生物 New peptide derivatives |
| 01/21/2003 | US6509463 Isocyanoalkylcarbonic acid derivatives, the reaction thereof in isocyanide multicomponent reactions to form sec-amido-alkylcarbonic acid derivatives, and those sec-amidoalkyl-carbonic acid derivatives |
| 01/17/2003 | WO2002006269A1 Cyclic amino acid derivatives |
| 01/17/2003 | CA2415964A1 Cyclic amino acid derivatives |
| 01/16/2003 | WO2002096415A3 Use of azetidinone substituted derivatives in the treatment of alzheimer's disease |
| 01/16/2003 | US20030013700 Thrombin inhibitors |
| 01/16/2003 | US20030013699 Methods for treating alzheimer's disease and/or regulating levels of amyloid beta peptides in a subject |
| 01/15/2003 | EP1275389A1 Compositions containing C7 Taxanes |
| 01/15/2003 | EP1023265B1 Azetidinone derivatives for the treatment of hcmv infections |
| 01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/14/2003 | US6506907 Process |
| 01/09/2003 | US20030009056 Process for the removal of nitrobenzenesulfonyl |
| 01/09/2003 | US20030009039 Reacting a beta -lactam with an alkoxide to form substituted isoserine ester compound |
| 01/08/2003 | EP1272467A1 Cathepsin cysteine protease inhibitors |
| 01/08/2003 | EP1021404B1 Azetidinone derivatives for the treatment of hcmv infections |
| 01/08/2003 | EP0859768B1 Amine acid salt compounds and process for the production thereof |
| 01/02/2003 | US20030004335 Process for the preparation of azetidones and intermediates thereof |
| 01/02/2003 | US20030004308 Anticoagulants |
| 01/02/2003 | US20030004151 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/02/2003 | US20030004138 Hypoglycemic agents; antidiabetic agents; dietetics |
| 01/02/2003 | EP1270562A2 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof |
| 01/02/2003 | EP1268396A1 Diphenyl ether compounds useful in therapy |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/25/2002 | CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 12/24/2002 | US6498170 4-((2s)-3-(1-(4-butoxy-benzenesulfonyl)-azetidin-3-ylamino)-2 -hydroxy- propoxy)-phenol for example; hypoglycemic agent; increasing lean meat to fat ratio in mammals |
| 12/24/2002 | US6498156 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
| 12/18/2002 | EP1265606A1 Cell adhesion inhibitors |
| 12/17/2002 | US6495704 Process for the preparation of a derivative or analog of baccatin iii or 10-desacetyl baccatin iii having a c9 substituent other than keto in which the c9 keto substituent of taxol, a taxol analog, baccatin iii or 10-desacetyl |
| 12/17/2002 | US6495568 Treatment of tissue ulceration, wound repair and skin diseases |
| 12/12/2002 | WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 12/12/2002 | CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 12/11/2002 | EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 12/11/2002 | EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 12/11/2002 | EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 12/11/2002 | CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 12/10/2002 | US6492402 Anticoagulants; peptide derivatives having high antithrombotic activity and oral bioavailability |
| 12/05/2002 | WO2002096415A2 Use of azetidinone substituted derivatives in the treatment of alzheimer's disease |
| 12/05/2002 | US20020183305 For therapy of hyperlipidemic conditions such as are associated with atherosclerosis, hypercholesterolemia and other vascular conditions in mammals |
| 12/05/2002 | CA2447884A1 Use of azetidinone substituted derivatives in the treatment of alzheimer's disease |
| 12/04/2002 | EP0690856B1 Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment |
| 12/03/2002 | US6489480 Coordination polymerization catalyst for alpha-olefins |
| 12/03/2002 | US6489352 Antiepileptic agents; nervous system disorders |
| 11/27/2002 | EP1260223A1 Taxanes having furyl or thienyl substituted side-chain |
| 11/27/2002 | EP1260222A1 Butenyl-substituted taxanes and composition |
| 11/26/2002 | CA2130333C Process for preparing .beta.-phenylisoserine and analogues thereof |
| 11/20/2002 | EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 11/20/2002 | EP1257533A1 New coupling process |
| 11/19/2002 | US6482963 C9 hydrido, hydroxy and acyloxy taxane derivatives and pharmaceutical compositions containing them |
| 11/14/2002 | US20020169318 Novel thrombin inhibitors |
| 11/14/2002 | US20020169134 Use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 11/13/2002 | EP1256572A1 Process for the deprotection of N-substituted azetidones |
| 11/13/2002 | EP0950057B1 3-pyridyl enantiomers and their use as analgesics |
| 11/12/2002 | US6479678 Metal alkoxide taxane and β-lactam compounds |
| 11/12/2002 | US6479524 To prolong the thrombin time |
| 11/12/2002 | US6479518 Zwitterionic tachykinin receptor antagonists |
| 11/12/2002 | US6479479 Azetidine derivatives, their preparation and pharmaceutical compositions containing them |
| 11/12/2002 | US6479078 Substantially crystalline form of melagatran |
| 11/07/2002 | WO2002088298A1 Compounds, compositions, and methods for controlling biofilms |
| 11/07/2002 | US20020165226 Estrogen receptor modulators |
| 11/07/2002 | US20020165223 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders |
| 11/07/2002 | CA2445591A1 Nitrogen heterocyclic compounds and compositions for controlling biofilms |
| 11/06/2002 | CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds |
| 11/05/2002 | US6476015 N-thiolated β-lactam antibiotics |